• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苏格兰经尿道前列腺切除术和开放性前列腺切除术后的死亡率。

Mortality after transurethral and open prostatectomy in Scotland.

作者信息

Hargreave T B, Heynes C F, Kendrick S W, Whyte B, Clarke J A

机构信息

Information and Statistics Division, National Health Service, Scotland.

出版信息

Br J Urol. 1996 Apr;77(4):547-53. doi: 10.1046/j.1464-410x.1996.95012.x.

DOI:10.1046/j.1464-410x.1996.95012.x
PMID:8777616
Abstract

OBJECTIVE

To use the linked medical and death records in Scotland to investigate the possible increased mortality that has been reported after transurethral prostatectomy (TURP) compared with open prostatectomy.

PATIENTS AND METHODS

Scotland has maintained linkable hospital, cancer and death records for more than 20 years, representing one of the largest such databases in the world. From these computerized records, data on various cohorts of men aged 55-84 years selected from 81,997 men who underwent prostatectomy in Scotland between 1968 and 1989 were analysed. The risk of late mortality was calculated for each type of operation, whether there was prior comorbidity and for a range of specific causes (cancer, respiratory and circulatory conditions) after prostatectomy.

RESULTS

Among the largest cohort, consisting of 65,519 men who underwent prostatectomy between 1968 and June 1989, the relative risk of late mortality after TURP compared with open prostatectomy was 1.13 (95% CI, 1.10-1.16), after controlling for age and the presence of a diagnosis of cancer. A more restricted cohort of 18,732 men who underwent prostatectomy between 1974 and 1979 allowed adjustment for prior hospitalization with, or concurrent diagnosis of, circulatory and respiratory conditions. In this cohort, the relative risk of late mortality after TURP as compared with open prostatectomy was 1.15 (95% CI, 1.11-1.19) after adjusting for prior and comorbidity and age. Finally, a cohort of 'healthy patients' restricted to the 6932 men who underwent prostatectomy from 1974 to 1979 and with no evidence of hospitalization in the previous 5 years or any current diagnosis other than benign hypertrophy of the prostate, showed a relative risk of 1.14 (95% CI, 1.07-1.21). There was no evidence of an increased risk of dying from circulatory disease in general, ischaemic heart disease or acute myocardial infarction after TURP as opposed to open prostatectomy. However, there was an increased risk of dying from respiratory conditions and from cancer, especially of the prostate and bladder. The analysis suggested the possibility that open prostatectomy may have cured some patients with early prostatic cancer, because the late death rate from prostatic cancer was greater in patients who underwent TURP than open prostatectomy.

CONCLUSION

The present analysis confirmed the increased risk of late mortality after TURP compared with open prostatectomy, as shown in previous studies based on administrative records. However, limitations in the coding of comorbidities and the absence of coding of more subtle aspects of the condition of the patient which may influence the choice between the forms of prostatectomy mean that the differential mortality after the two procedures could still be a reflection of the pre-operative selection of patients rather than the effects of the surgical procedure.

摘要

目的

利用苏格兰的医学与死亡记录联动系统,调查经尿道前列腺切除术(TURP)与开放性前列腺切除术相比,是否存在已报道的可能增加的死亡率。

患者与方法

苏格兰已维持可联动的医院、癌症及死亡记录超过20年,这是世界上最大的此类数据库之一。从这些计算机化记录中,分析了从1968年至1989年在苏格兰接受前列腺切除术的81997名男性中选取的55 - 84岁不同队列男性的数据。计算了每种手术类型、是否存在术前合并症以及前列腺切除术后一系列特定病因(癌症、呼吸系统和循环系统疾病)的晚期死亡风险。

结果

在最大的队列中,由1968年至1989年6月间接受前列腺切除术的65519名男性组成,在控制年龄和癌症诊断情况后,TURP术后晚期死亡的相对风险与开放性前列腺切除术相比为1.13(95%可信区间,1.10 - 1.16)。一个更受限的队列由1974年至1979年间接受前列腺切除术的18732名男性组成,可对循环系统和呼吸系统疾病的术前住院或同期诊断情况进行调整。在这个队列中,调整术前合并症和年龄后,TURP术后晚期死亡的相对风险与开放性前列腺切除术相比为1.15(95%可信区间,1.11 - 1.19)。最后,一个“健康患者”队列限定为1974年至1979年间接受前列腺切除术且在过去5年无住院证据或除前列腺良性增生外无任何当前诊断的6932名男性,其相对风险为1.14(95%可信区间,1.07 - 1.21)。与开放性前列腺切除术相比,没有证据表明TURP术后总体循环系统疾病、缺血性心脏病或急性心肌梗死的死亡风险增加。然而,呼吸系统疾病和癌症,尤其是前列腺癌和膀胱癌的死亡风险增加。分析表明开放性前列腺切除术可能治愈了一些早期前列腺癌患者,因为TURP术后前列腺癌的晚期死亡率高于开放性前列腺切除术。

结论

本分析证实了与开放性前列腺切除术相比,TURP术后晚期死亡风险增加,正如先前基于行政记录的研究所显示的那样。然而,合并症编码的局限性以及患者病情更细微方面未进行编码,这些方面可能会影响前列腺切除术形式的选择,这意味着两种手术术后的死亡率差异仍可能反映患者的术前选择而非手术操作的影响。

相似文献

1
Mortality after transurethral and open prostatectomy in Scotland.苏格兰经尿道前列腺切除术和开放性前列腺切除术后的死亡率。
Br J Urol. 1996 Apr;77(4):547-53. doi: 10.1046/j.1464-410x.1996.95012.x.
2
Mortality and prostate cancer risk in 19,598 men after surgery for benign prostatic hyperplasia.19598名良性前列腺增生手术后男性的死亡率和前列腺癌风险
BJU Int. 1999 Jul;84(1):37-42. doi: 10.1046/j.1464-410x.1999.00123.x.
3
Problems of comorbidity in mortality after prostatectomy.前列腺切除术后死亡率中的共病问题。
JAMA. 1992 Feb 26;267(8):1077-82.
4
Reoperation Rates and Mortality After Transurethral and Open Prostatectomy in a Long-term Nationwide Analysis: Have We Improved Over a Decade?一项全国性长期分析中经尿道前列腺切除术和开放性前列腺切除术后的再次手术率及死亡率:过去十年我们有进步吗?
Urology. 2018 Aug;118:152-157. doi: 10.1016/j.urology.2018.04.032. Epub 2018 May 4.
5
Trends in repeat prostatectomy after surgery for benign prostate disease: application of record linkage to healthcare outcomes.良性前列腺疾病手术后再次前列腺切除术的趋势:记录链接在医疗结果中的应用。
BJU Int. 1999 Dec;84(9):972-5. doi: 10.1046/j.1464-410x.1999.00359.x.
6
Incidence of acute myocardial infarction and cause-specific mortality after transurethral treatments of prostatic hypertrophy.经尿道前列腺增生治疗后急性心肌梗死的发生率及特定病因死亡率。
Urology. 2000 Feb;55(2):236-40. doi: 10.1016/s0090-4295(99)00417-3.
7
Reoperation and mortality after surgical treatment of benign prostatic hypertrophy in a large prepaid medical care program.大型预付式医疗保健项目中良性前列腺增生手术治疗后的再次手术及死亡率
Med Care. 1992 Feb;30(2):117-25. doi: 10.1097/00005650-199202000-00003.
8
Elevated mortality following transurethral resection of the prostate for benign hypertrophy! But why?经尿道前列腺切除术治疗良性前列腺增生后死亡率升高!但原因何在?
Med Care. 1990 Oct;28(10):870-81. doi: 10.1097/00005650-199010000-00002.
9
SURGICAL MANAGEMENT OF BPH IN GHANA: A NEED TO IMPROVE ACCESS TO TRANSURETHRAL RESECTION OF THE PROSTATE.加纳良性前列腺增生症的外科治疗:改善前列腺经尿道切除术可及性的必要性
East Afr Med J. 2012 Jul;89(7):241-5.
10
Deaths and complications following prostatectomy in 1400 men in the northern region of England. Northern Regional Prostate Audit Group.英格兰北部地区1400名男性前列腺切除术后的死亡情况及并发症。北部地区前列腺审计小组。
Br J Urol. 1994 Nov;74(5):559-65. doi: 10.1111/j.1464-410x.1994.tb09184.x.

引用本文的文献

1
[Surgical treatment of male lower urinary tract symptoms (LUTS)].男性下尿路症状(LUTS)的外科治疗
Urologe A. 2012 Sep;51(9):1297-306; quiz 1307. doi: 10.1007/s00120-012-2959-6.
2
[Benign prostatic hyperplasia (BPH) : Surgical therapy options].[良性前列腺增生(BPH):手术治疗方案]
Urologe A. 2010 Jan;49(1):113-26. doi: 10.1007/s00120-009-2183-1.
3
[Therapy of benign prostate syndrome (BPS): guidelines of the German Urologists (DGU)].[良性前列腺综合征(BPS)的治疗:德国泌尿外科医师协会(DGU)指南]
Urologe A. 2009 Dec;48(12):1503-16. doi: 10.1007/s00120-009-2067-4.
4
[Benign prostatic syndrome (BPS). Ablative treatments].[良性前列腺综合征(BPS)。消融治疗]
Urologe A. 2006 Jun;45(6):769-80; quiz 781-2. doi: 10.1007/s00120-006-1039-1.
5
[Blood loss and absorption in TURP vs. TUVRP under low pressure and high pressure conditions].[经尿道前列腺切除术(TURP)与经尿道汽化电切术(TUVRP)在低压和高压条件下的失血与吸收情况]
Urologe A. 2003 Nov;42(11):1477-84. doi: 10.1007/s00120-003-0353-0. Epub 2003 Apr 16.
6
Changing therapeutic regimens in benign prostatic hyperplasia. Clinical and economic considerations.良性前列腺增生治疗方案的变更:临床与经济考量
Pharmacoeconomics. 2001;19(2):131-53. doi: 10.2165/00019053-200119020-00003.